Nauffal, Victor http://orcid.org/0000-0001-7199-299X
Di Achille, Paolo http://orcid.org/0000-0001-9256-0678
Klarqvist, Marcus D. R. http://orcid.org/0000-0001-7630-2708
Cunningham, Jonathan W. http://orcid.org/0000-0003-4481-7867
Hill, Matthew C.
Pirruccello, James P. http://orcid.org/0000-0001-6088-4037
Weng, Lu-Chen http://orcid.org/0000-0003-1475-4930
Morrill, Valerie N.
Choi, Seung Hoan http://orcid.org/0000-0002-2797-3190
Khurshid, Shaan
Friedman, Samuel F. http://orcid.org/0000-0002-0688-2169
Nekoui, Mahan
Roselli, Carolina http://orcid.org/0000-0001-5267-6756
Ng, Kenney
Philippakis, Anthony A. http://orcid.org/0000-0001-6953-3794
Batra, Puneet http://orcid.org/0000-0001-6822-0593
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Lubitz, Steven A. http://orcid.org/0000-0002-9599-4866
Funding for this research was provided by:
Foundation for the National Institutes of Health (1R01HL139731, T32HL007604, K08HL159346, 1R01HL139731, K24HL105780, 1R01HL092577, 5T32HL007208-42)
American Heart Association (18SFRN34250007, 18SFRN34110082, 18SFRN34110082)
Fondation Leducq (14CVD01)
Article History
Received: 5 November 2021
Accepted: 13 March 2023
First Online: 20 April 2023
Competing interests
: M.D.R.K., P.D.A., S.F.F. and P.B. are supported by grants from Bayer and IBM with regard to applying machine learning in cardiovascular disease. P.B. serves as a consultant for Novartis and Prometheus Biosciences and is employed by Flagship Pioneering as of 4 January 2023. C.R. is supported by a grant from Bayer to the Broad Institute, which is focused on the development of therapeutics for cardiovascular disease. S.A.L. is employed by Novartis Institutes for Biomedical Research as of 18 July 2022. S.A.L. received sponsored research support from Bristol Myers Squibb, Pfizer, Bayer, Boehringer Ingelheim, Fitbit and IBM, and has previously consulted for Bristol Myers Squibb, Pfizer, Bayer, Blackstone Life Sciences and Invitae. P.T.E. receives sponsored research support from Bayer, Novartis, MyoKardia and Quest. L.-C.W. receives sponsored research support from IBM to the Broad Institute. The other authors declare no competing interests.